Medicine

New Jersey Enters Multi-State Settlement With Merck, Schering-Plough On Vytorin

TRENTON—New Jersey has entered into a multi-state settlement with Merck & Co. Inc, Schering-Plough Corporation, and a joint venture of the two companies, MSP Singapore Company, LLC, resolving an investigation into a lengthy delay by the companies in issuing negative results from a clinical trial of their cholesterol-lowering drug Vytorin, Attorney General Anne Milgram announced today.